Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Krzysztof Ossoliński"'
Autor:
Joanna Nizioł, Krzysztof Ossoliński, Aneta Płaza-Altamer, Artur Kołodziej, Anna Ossolińska, Tadeusz Ossoliński, Anna Nieczaj, Tomasz Ruman
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-15 (2023)
Abstract Bladder cancer (BC) is a common urological malignancy with a high probability of death and recurrence. Cystoscopy is used as a routine examination for diagnosis and following patient monitoring for recurrence. Repeated costly and intrusive t
Externí odkaz:
https://doaj.org/article/bcbe45b7c7e344fb93e852c37d551b33
Autor:
Krzysztof Ossoliński, Tomasz Ruman, Valérie Copié, Brian P. Tripet, Leonardo B. Nogueira, Katiane O.P.C. Nogueira, Artur Kołodziej, Aneta Płaza-Altamer, Anna Ossolińska, Tadeusz Ossoliński, Joanna Nizioł
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 12, Iss 6, Pp 889-900 (2022)
Bladder cancer (BC) is one of the most frequently diagnosed types of urinary cancer. Despite advances in treatment methods, no specific biomarkers are currently in use. Targeted and untargeted profiling of metabolites and elements of human blood seru
Externí odkaz:
https://doaj.org/article/62e9b1f352194e8f9d72fda067f25e95
Autor:
Joanna Nizioł, Krzysztof Ossoliński, Aneta Płaza-Altamer, Artur Kołodziej, Anna Ossolińska, Tadeusz Ossoliński, Tomasz Ruman
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Bladder cancer (BC) is a common urological cancer of high mortality and recurrence rates. Currently, cystoscopy is performed as standard examination for the diagnosis and subsequent monitoring for recurrence of the patients. Frequent expensi
Externí odkaz:
https://doaj.org/article/cff1796d372745448ae908543c061547
Autor:
Artur Kowalik, Andrzej Wincewicz, Krzysztof Ossoliński, Sebastian Zięba, Janusz Kopczyński, Tadeusz Ossoliński, Stanisław Góźdź, Mariusz Koda, Stanisław Sulkowski
Publikováno v:
Polish Journal of Pathology, Vol 71, Iss 3, Pp 195-199 (2020)
Here we review the role of GDNF, PTCH1, RNF213 illustrated by a case of renal cell carcinoma, chromophobe type (pT2a 8th pTNM edition) of the left kidney of 71-year-old man. Status of potential hotspots in 409 tumor genes were studied by means of nex
Externí odkaz:
https://doaj.org/article/740a50f8d45644bc844ac22ecf9af316
Autor:
Krzysztof Ossoliński, Tomasz Ruman, Valérie Copié, Brian P. Tripet, Artur Kołodziej, Aneta Płaza-Altamer, Anna Ossolińska, Tadeusz Ossoliński, Anna Nieczaj, Joanna Nizioł
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6247ce678c3a4ec681562e07b4018850
https://doi.org/10.2139/ssrn.4434796
https://doi.org/10.2139/ssrn.4434796
Autor:
Krzysztof Ossoliński, Tomasz Ruman, Tadeusz Ossoliński, Anna Ossolińska, Adrian Arendowski, Artur Kołodziej, Aneta Płaza-Altamer, Joanna Nizioł
Publikováno v:
Advances in medical sciences. 68(1)
Bladder cancer (BC) is the 10th most common form of cancer worldwide and the 2nd most common cancer of the urinary tract after prostate cancer, taking into account both incidence and prevalence.Tissues from patients with BC and also tissue extracts w
Autor:
Adrian Arendowski, Krzysztof Ossoliński, Valérie Copié, Tomasz Ruman, Joanna Nizioł, Brian P. Tripet
Publikováno v:
Analytical and Bioanalytical Chemistry
Kidney cancer is one of the most frequently diagnosed and the most lethal urinary cancer. Despite all the efforts made, no serum-specific biomarker is currently used in the clinical management of patients with this tumor. In this study, comprehensive
Autor:
Iwona Beech, Jan Sunner, Tadeusz Ossoliński, Aneta Płaza, Tomasz Ruman, Joanna Nizioł, Krzysztof Ossoliński, Anna Ossolińska
Publikováno v:
Analytical Chemistry
Infrared (IR) laser ablation-remote-electrospray ionization (LARESI) platform coupled to a tandem mass spectrometer (MS/MS) operated in selected reaction monitoring (SRM) or multiple reaction monitoring (MRM) modes was developed and employed for imag
Autor:
Adrian Arendowski, Krzysztof Ossoliński, Tadeusz Ossoliński, Anna Ossolińska, Tomasz Ruman, Joanna Nizioł
Publikováno v:
Advances in medical sciences. 66(2)
Purpose Renal cell carcinoma (RCC) is a very aggressive and often fatal heterogeneous disease that is usually asymptomatic until late in the disease. There is an urgent need for RCC specific biomarkers that may be exploited clinically for diagnostic
Autor:
Adrian Arendowski, Leonardo Brandão Nogueira, Katiane de Oliveira Pinto Coelho Nogueira, Valérie Copié, Tomasz Ruman, Joanna Nizioł, Krzysztof Ossoliński, Brian P. Tripet
Publikováno v:
Metabolomics
Introduction Kidney cancer is one of the most frequently diagnosed and the most lethal urinary cancer. Despite advances in treatment, no specific biomarker is currently in use to guide therapeutic interventions. Objectives Major aim of this work was